ClariTrial | Search Clinical Trials

Explore/Cancer

Status

Phase

145,214 results for “Cancer”

Page 1 of 9681

Recruiting

JAB-2485 Activity in Adult Patients With Advanced Solid Tumors

Phase 1Phase 2Solid TumorsER+ Breast CancerTriple Negative Breast Cancer, TNBC

JAB-2485 (Aurora A inhibitor)JAB-2485 (Aurora A inhibitor)

Jacobio Pharmaceuticals Co., Ltd.102 participants8 sites · United States, ChinaCompletes Aug 2026

Compare CT.gov Full analysis →

Not Yet Recruiting

Early Prophylactic rhTPO Administration for Thrombocytopenia Associated With EAP Regimen-Based Hematopoietic Stem Cell Mobilization

Phase 2Phase 3Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), LymphomaHematopoietic Stem Cell MobilizationChemotherapy-Induced Thrombocytopenia

rhTPO prophylaxis plus EAP stem-cell mobilization

The Affiliated People's Hospital of Ningbo University70 participantsCompletes Dec 2029

Compare CT.gov Full analysis →

Recruiting

PRRT Versus PRRT Plus Chemotherapy in GEP NET (PReCedeNT Trial)

Phase 3Neuroendocrine Neoplasia's (NENs)Neuroendocrine Tumor GEP Grade 1-3Neuroendocrine Gastroenteropancreatic Tumour

Peptide Receptor Radionuclide Therapy with Lu177 DOTATATECapecitabine plus temozolamide

Tata Memorial Hospital162 participants2 sites · IndiaCompletes Aug 2027

Compare CT.gov Full analysis →

Completed

Results posted

A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma

Phase 3Newly Diagnosed Glioblastoma

MarizomibTemozolomideradiotherapy

European Organisation for Research and Treatment of Cancer - EORTC749 participants82 sites · United States, Austria, BelgiumCompletes Aug 2022

Compare CT.gov Full analysis →

Completed

Results posted

VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2

Phase 2Anal Neoplasm

VGX-3100CELLECTRA™ 5PSP

Inovio Pharmaceuticals23 participants3 sites · United States, CanadaCompletes Jun 2020

Compare CT.gov Full analysis →

Recruiting

A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas

Phase 1Phase 2Relapsed/Refractory Non-Hodgkin Lymphoma

BMS-986458RituximabGlofitamab/Obinutuzumab+3 more

Bristol-Myers Squibb460 participants75 sites · United States, Chile, ChinaCompletes Oct 2027

Compare CT.gov Full analysis →

Completed

Hypofractionated Stereotactic Radiotherapy for Patients With Recurrent High Grade Glioma

N/ARecurrent High Grade Glioma

IMRT with or without radiosensitive therapyRadiosensitive therapy

Istituto Clinico Humanitas88 participants1 site · ItalyCompletes Jun 2022

Compare CT.gov Full analysis →

UNKNOWN

Investigation of High Resolution Nuclear Breast Imaging Camera (MBI) in Patients Administered Tc-99m Sestamibi (ROSE)

N/ABreast Lesions

Hamilton Health Sciences Corporation150 participants1 site · CanadaCompletes Sep 2012

Compare CT.gov Full analysis →

Completed

Open Label Phase I/Randomised,Double Blind Phase II Study in mCRPC of AZD5363 In Combination With DP Chemotherapy

Phase 1Phase 2Prostate Cancer

PlaceboAZD5363

University Hospital Southampton NHS Foundation Trust160 participants1 site · United KingdomCompletes Oct 2020

Compare CT.gov Full analysis →

UNKNOWN

Comparing Transperineal to Transrectal MRI-US Fusion Prostate Biopsy

N/AProstate Biopsy

Transperineal mpMRI-US Fusion prostate biopsyTransrectal mpMRI-US Fusion prostate biopsy

Rabin Medical Center76 participants1 site · IsraelCompletes Oct 2019

Compare CT.gov Full analysis →

Withdrawn

Melphalan on Disease Burden Measured by Next Generation Sequencing Before AHCT (Autologous Hematopoietic Cell Transplant) for Multiple Myeloma

Early Phase 1Multiple Myeloma

EvomelaNext Generation SequencingProchlorperazine+2 more

Koen van Besien01 site · United StatesCompletes Dec 2023

Compare CT.gov Full analysis →

Completed

Physical Activity in Rectal Cancer Survivors

N/ARectal CancerRectosigmoid Cancer

Physical ActivitySurveyTelehealth Lifestyle Coaching

Abramson Cancer Center at Penn Medicine20 participants1 site · United StatesCompletes Mar 2024

Compare CT.gov Full analysis →

Completed

Robotic vs Laparoscopic and Open Surgery for Abdominopelvic Cancers

N/APancreatic NeoplasmsStomach NeoplasmsRectal Neoplasms

No Intervention: Observational Cohort

Asan Medical Center32,949 participants1 site · South KoreaCompletes Dec 2022

Compare CT.gov Full analysis →

Recruiting

Neratinib in Combination With Ruxolitinib in Patients With mTNBC

Early Phase 1Metastatic Triple-Negative Breast CarcinomaBreast Cancer

Neratinib Oral TabletRuxolitinib Oral Tablet

Baylor Research Institute20 participants1 site · United StatesCompletes Jun 2027

Compare CT.gov Full analysis →

Completed

Results posted

Hypovitaminosis D in Neurocritical Patients

Phase 2Phase 3Craniocerebral TraumaIntracranial AneurysmBrain Neoplasms

CholecalciferolPlacebo

University of Utah274 participants1 site · United StatesCompletes Oct 2018

Compare CT.gov Full analysis →

1–15 of 145,214

Explore/Cancer

Status

Phase

145,214 results for “Cancer”

Page 1 of 9681

Recruiting

JAB-2485 Activity in Adult Patients With Advanced Solid Tumors

Phase 1Phase 2Solid TumorsER+ Breast CancerTriple Negative Breast Cancer, TNBC

JAB-2485 (Aurora A inhibitor)JAB-2485 (Aurora A inhibitor)

Jacobio Pharmaceuticals Co., Ltd.102 participants8 sites · United States, ChinaCompletes Aug 2026

Compare CT.gov Full analysis →

Not Yet Recruiting

Early Prophylactic rhTPO Administration for Thrombocytopenia Associated With EAP Regimen-Based Hematopoietic Stem Cell Mobilization

Phase 2Phase 3Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), LymphomaHematopoietic Stem Cell MobilizationChemotherapy-Induced Thrombocytopenia

rhTPO prophylaxis plus EAP stem-cell mobilization

The Affiliated People's Hospital of Ningbo University70 participantsCompletes Dec 2029

Compare CT.gov Full analysis →

Recruiting

PRRT Versus PRRT Plus Chemotherapy in GEP NET (PReCedeNT Trial)

Phase 3Neuroendocrine Neoplasia's (NENs)Neuroendocrine Tumor GEP Grade 1-3Neuroendocrine Gastroenteropancreatic Tumour

Peptide Receptor Radionuclide Therapy with Lu177 DOTATATECapecitabine plus temozolamide

Tata Memorial Hospital162 participants2 sites · IndiaCompletes Aug 2027

Compare CT.gov Full analysis →

Completed

Results posted

A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma

Phase 3Newly Diagnosed Glioblastoma

MarizomibTemozolomideradiotherapy

European Organisation for Research and Treatment of Cancer - EORTC749 participants82 sites · United States, Austria, BelgiumCompletes Aug 2022

Compare CT.gov Full analysis →

Completed

Results posted

Phase 2Anal Neoplasm

VGX-3100CELLECTRA™ 5PSP

Inovio Pharmaceuticals23 participants3 sites · United States, CanadaCompletes Jun 2020

Compare CT.gov Full analysis →

Recruiting

A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas

Phase 1Phase 2Relapsed/Refractory Non-Hodgkin Lymphoma

BMS-986458RituximabGlofitamab/Obinutuzumab+3 more

Bristol-Myers Squibb460 participants75 sites · United States, Chile, ChinaCompletes Oct 2027

Compare CT.gov Full analysis →

Completed

Hypofractionated Stereotactic Radiotherapy for Patients With Recurrent High Grade Glioma

N/ARecurrent High Grade Glioma

IMRT with or without radiosensitive therapyRadiosensitive therapy

Istituto Clinico Humanitas88 participants1 site · ItalyCompletes Jun 2022

Compare CT.gov Full analysis →

UNKNOWN

Investigation of High Resolution Nuclear Breast Imaging Camera (MBI) in Patients Administered Tc-99m Sestamibi (ROSE)

N/ABreast Lesions

Hamilton Health Sciences Corporation150 participants1 site · CanadaCompletes Sep 2012

Compare CT.gov Full analysis →

Completed

Open Label Phase I/Randomised,Double Blind Phase II Study in mCRPC of AZD5363 In Combination With DP Chemotherapy

Phase 1Phase 2Prostate Cancer

PlaceboAZD5363

University Hospital Southampton NHS Foundation Trust160 participants1 site · United KingdomCompletes Oct 2020

Compare CT.gov Full analysis →

UNKNOWN

Comparing Transperineal to Transrectal MRI-US Fusion Prostate Biopsy

N/AProstate Biopsy

Transperineal mpMRI-US Fusion prostate biopsyTransrectal mpMRI-US Fusion prostate biopsy

Rabin Medical Center76 participants1 site · IsraelCompletes Oct 2019

Compare CT.gov Full analysis →

Withdrawn

Melphalan on Disease Burden Measured by Next Generation Sequencing Before AHCT (Autologous Hematopoietic Cell Transplant) for Multiple Myeloma

Early Phase 1Multiple Myeloma

EvomelaNext Generation SequencingProchlorperazine+2 more

Koen van Besien01 site · United StatesCompletes Dec 2023

Compare CT.gov Full analysis →

Completed

Physical Activity in Rectal Cancer Survivors

N/ARectal CancerRectosigmoid Cancer

Physical ActivitySurveyTelehealth Lifestyle Coaching

Abramson Cancer Center at Penn Medicine20 participants1 site · United StatesCompletes Mar 2024

Compare CT.gov Full analysis →

Completed

Robotic vs Laparoscopic and Open Surgery for Abdominopelvic Cancers

N/APancreatic NeoplasmsStomach NeoplasmsRectal Neoplasms

No Intervention: Observational Cohort

Asan Medical Center32,949 participants1 site · South KoreaCompletes Dec 2022

Compare CT.gov Full analysis →

Recruiting

Neratinib in Combination With Ruxolitinib in Patients With mTNBC

Early Phase 1Metastatic Triple-Negative Breast CarcinomaBreast Cancer

Neratinib Oral TabletRuxolitinib Oral Tablet

Baylor Research Institute20 participants1 site · United StatesCompletes Jun 2027

Compare CT.gov Full analysis →

Completed

Results posted

Hypovitaminosis D in Neurocritical Patients

Phase 2Phase 3Craniocerebral TraumaIntracranial AneurysmBrain Neoplasms

CholecalciferolPlacebo

University of Utah274 participants1 site · United StatesCompletes Oct 2018

Compare CT.gov Full analysis →

1–15 of 145,214